Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Carlsmed (CARL) Cash from Operations (2024 - 2026)

Carlsmed filings provide 2 years of Cash from Operations readings, the most recent being 5321000.0 for Q4 2025.

On a quarterly basis, Cash from Operations fell 26.6% to 5321000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 25563000.0, a N/A change, with the full-year FY2025 number at 28977000.0, down 13.79% from a year prior.
Cash from Operations hit 5321000.0 in Q4 2025 for Carlsmed, up from 8459000.0 in the prior quarter.
In the past five years, Cash from Operations ranged from a high of 4203000.0 in Q4 2024 to a low of 8459000.0 in Q3 2025.